Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002015003 | SCV002281277 | uncertain significance | Glycogen storage disease, type II | 2020-12-17 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GAA protein function. This variant has not been reported in the literature in individuals with GAA-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with glutamic acid at codon 116 of the GAA protein (p.Gly116Glu). The glycine residue is weakly conserved and there is a moderate physicochemical difference between glycine and glutamic acid. |
Revvity Omics, |
RCV003138021 | SCV003828468 | uncertain significance | not provided | 2019-04-10 | criteria provided, single submitter | clinical testing |